United States Transcutaneous Neurostimulators Market Report 2017

January 2018 | 97 pages | ID: U4DE331DC5FEN
QYResearch

Abstracts

In this report, the United States Transcutaneous Neurostimulators market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Transcutaneous Neurostimulators in these regions, from 2012 to 2022 (forecast).

United States Transcutaneous Neurostimulators market competition by top manufacturers/players, with Transcutaneous Neurostimulators sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• ElectroCore Medical
• NEUROMetrix
• Neurosigma
• Quell
• Vygon

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Sensory Nerve Stimulation
• Vagus Nerve Stimulation
• Peripheral Nerve Stimulation

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospiatl
• Clinic

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Transcutaneous Neurostimulators Market Report 2017

1 TRANSCUTANEOUS NEUROSTIMULATORS OVERVIEW

1.1 Product Overview and Scope of Transcutaneous Neurostimulators
1.2 Classification of Transcutaneous Neurostimulators by Product Category
  1.2.1 United States Transcutaneous Neurostimulators Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Transcutaneous Neurostimulators Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Sensory Nerve Stimulation
  1.2.4 Vagus Nerve Stimulation
  1.2.5 Peripheral Nerve Stimulation
1.3 United States Transcutaneous Neurostimulators Market by Application/End Users
  1.3.1 United States Transcutaneous Neurostimulators Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospiatl
  1.3.3 Clinic
1.4 United States Transcutaneous Neurostimulators Market by Region
  1.4.1 United States Transcutaneous Neurostimulators Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Transcutaneous Neurostimulators Status and Prospect (2012-2022)
  1.4.3 Southwest Transcutaneous Neurostimulators Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Transcutaneous Neurostimulators Status and Prospect (2012-2022)
  1.4.5 New England Transcutaneous Neurostimulators Status and Prospect (2012-2022)
  1.4.6 The South Transcutaneous Neurostimulators Status and Prospect (2012-2022)
  1.4.7 The Midwest Transcutaneous Neurostimulators Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Transcutaneous Neurostimulators (2012-2022)
  1.5.1 United States Transcutaneous Neurostimulators Sales and Growth Rate (2012-2022)
  1.5.2 United States Transcutaneous Neurostimulators Revenue and Growth Rate (2012-2022)

2 UNITED STATES TRANSCUTANEOUS NEUROSTIMULATORS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Transcutaneous Neurostimulators Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Transcutaneous Neurostimulators Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Transcutaneous Neurostimulators Average Price by Players/Suppliers (2012-2017)
2.4 United States Transcutaneous Neurostimulators Market Competitive Situation and Trends
  2.4.1 United States Transcutaneous Neurostimulators Market Concentration Rate
  2.4.2 United States Transcutaneous Neurostimulators Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Transcutaneous Neurostimulators Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES TRANSCUTANEOUS NEUROSTIMULATORS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Transcutaneous Neurostimulators Sales and Market Share by Region (2012-2017)
3.2 United States Transcutaneous Neurostimulators Revenue and Market Share by Region (2012-2017)
3.3 United States Transcutaneous Neurostimulators Price by Region (2012-2017)

4 UNITED STATES TRANSCUTANEOUS NEUROSTIMULATORS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Transcutaneous Neurostimulators Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Transcutaneous Neurostimulators Revenue and Market Share by Type (2012-2017)
4.3 United States Transcutaneous Neurostimulators Price by Type (2012-2017)
4.4 United States Transcutaneous Neurostimulators Sales Growth Rate by Type (2012-2017)

5 UNITED STATES TRANSCUTANEOUS NEUROSTIMULATORS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Transcutaneous Neurostimulators Sales and Market Share by Application (2012-2017)
5.2 United States Transcutaneous Neurostimulators Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES TRANSCUTANEOUS NEUROSTIMULATORS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 ElectroCore Medical
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Transcutaneous Neurostimulators Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 ElectroCore Medical Transcutaneous Neurostimulators Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 NEUROMetrix
  6.2.2 Transcutaneous Neurostimulators Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 NEUROMetrix Transcutaneous Neurostimulators Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Neurosigma
  6.3.2 Transcutaneous Neurostimulators Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Neurosigma Transcutaneous Neurostimulators Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Quell
  6.4.2 Transcutaneous Neurostimulators Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Quell Transcutaneous Neurostimulators Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Vygon
  6.5.2 Transcutaneous Neurostimulators Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Vygon Transcutaneous Neurostimulators Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview

7 TRANSCUTANEOUS NEUROSTIMULATORS MANUFACTURING COST ANALYSIS

7.1 Transcutaneous Neurostimulators Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Transcutaneous Neurostimulators

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Transcutaneous Neurostimulators Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Transcutaneous Neurostimulators Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES TRANSCUTANEOUS NEUROSTIMULATORS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Transcutaneous Neurostimulators Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Transcutaneous Neurostimulators Sales Volume Forecast by Type (2017-2022)
11.3 United States Transcutaneous Neurostimulators Sales Volume Forecast by Application (2017-2022)
11.4 United States Transcutaneous Neurostimulators Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Transcutaneous Neurostimulators
Figure United States Transcutaneous Neurostimulators Market Size (K Units) by Type (2012-2022)
Figure United States Transcutaneous Neurostimulators Sales Volume Market Share by Type (Product Category) in 2016
Figure Sensory Nerve Stimulation Product Picture
Figure Vagus Nerve Stimulation Product Picture
Figure Peripheral Nerve Stimulation Product Picture
Figure United States Transcutaneous Neurostimulators Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Transcutaneous Neurostimulators by Application in 2016
Figure Hospiatl Examples
Table Key Downstream Customer in Hospiatl
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure United States Transcutaneous Neurostimulators Market Size (Million USD) by Region (2012-2022)
Figure The West Transcutaneous Neurostimulators Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Transcutaneous Neurostimulators Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Transcutaneous Neurostimulators Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Transcutaneous Neurostimulators Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Transcutaneous Neurostimulators Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Transcutaneous Neurostimulators Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Transcutaneous Neurostimulators Sales (K Units) and Growth Rate (2012-2022)
Figure United States Transcutaneous Neurostimulators Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Transcutaneous Neurostimulators Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Transcutaneous Neurostimulators Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Transcutaneous Neurostimulators Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Transcutaneous Neurostimulators Sales Share by Players/Suppliers
Figure 2017 United States Transcutaneous Neurostimulators Sales Share by Players/Suppliers
Figure United States Transcutaneous Neurostimulators Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Transcutaneous Neurostimulators Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Transcutaneous Neurostimulators Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Transcutaneous Neurostimulators Revenue Share by Players/Suppliers
Figure 2017 United States Transcutaneous Neurostimulators Revenue Share by Players/Suppliers
Table United States Market Transcutaneous Neurostimulators Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Transcutaneous Neurostimulators Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Transcutaneous Neurostimulators Market Share of Top 3 Players/Suppliers
Figure United States Transcutaneous Neurostimulators Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Transcutaneous Neurostimulators Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Transcutaneous Neurostimulators Product Category
Table United States Transcutaneous Neurostimulators Sales (K Units) by Region (2012-2017)
Table United States Transcutaneous Neurostimulators Sales Share by Region (2012-2017)
Figure United States Transcutaneous Neurostimulators Sales Share by Region (2012-2017)
Figure United States Transcutaneous Neurostimulators Sales Market Share by Region in 2016
Table United States Transcutaneous Neurostimulators Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Transcutaneous Neurostimulators Revenue Share by Region (2012-2017)
Figure United States Transcutaneous Neurostimulators Revenue Market Share by Region (2012-2017)
Figure United States Transcutaneous Neurostimulators Revenue Market Share by Region in 2016
Table United States Transcutaneous Neurostimulators Price (USD/Unit) by Region (2012-2017)
Table United States Transcutaneous Neurostimulators Sales (K Units) by Type (2012-2017)
Table United States Transcutaneous Neurostimulators Sales Share by Type (2012-2017)
Figure United States Transcutaneous Neurostimulators Sales Share by Type (2012-2017)
Figure United States Transcutaneous Neurostimulators Sales Market Share by Type in 2016
Table United States Transcutaneous Neurostimulators Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Transcutaneous Neurostimulators Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Transcutaneous Neurostimulators by Type (2012-2017)
Figure Revenue Market Share of Transcutaneous Neurostimulators by Type in 2016
Table United States Transcutaneous Neurostimulators Price (USD/Unit) by Types (2012-2017)
Figure United States Transcutaneous Neurostimulators Sales Growth Rate by Type (2012-2017)
Table United States Transcutaneous Neurostimulators Sales (K Units) by Application (2012-2017)
Table United States Transcutaneous Neurostimulators Sales Market Share by Application (2012-2017)
Figure United States Transcutaneous Neurostimulators Sales Market Share by Application (2012-2017)
Figure United States Transcutaneous Neurostimulators Sales Market Share by Application in 2016
Table United States Transcutaneous Neurostimulators Sales Growth Rate by Application (2012-2017)
Figure United States Transcutaneous Neurostimulators Sales Growth Rate by Application (2012-2017)
Table ElectroCore Medical Basic Information List
Table ElectroCore Medical Transcutaneous Neurostimulators Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure ElectroCore Medical Transcutaneous Neurostimulators Sales Growth Rate (2012-2017)
Figure ElectroCore Medical Transcutaneous Neurostimulators Sales Market Share in United States (2012-2017)
Figure ElectroCore Medical Transcutaneous Neurostimulators Revenue Market Share in United States (2012-2017)
Table NEUROMetrix Basic Information List
Table NEUROMetrix Transcutaneous Neurostimulators Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure NEUROMetrix Transcutaneous Neurostimulators Sales Growth Rate (2012-2017)
Figure NEUROMetrix Transcutaneous Neurostimulators Sales Market Share in United States (2012-2017)
Figure NEUROMetrix Transcutaneous Neurostimulators Revenue Market Share in United States (2012-2017)
Table Neurosigma Basic Information List
Table Neurosigma Transcutaneous Neurostimulators Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Neurosigma Transcutaneous Neurostimulators Sales Growth Rate (2012-2017)
Figure Neurosigma Transcutaneous Neurostimulators Sales Market Share in United States (2012-2017)
Figure Neurosigma Transcutaneous Neurostimulators Revenue Market Share in United States (2012-2017)
Table Quell Basic Information List
Table Quell Transcutaneous Neurostimulators Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Quell Transcutaneous Neurostimulators Sales Growth Rate (2012-2017)
Figure Quell Transcutaneous Neurostimulators Sales Market Share in United States (2012-2017)
Figure Quell Transcutaneous Neurostimulators Revenue Market Share in United States (2012-2017)
Table Vygon Basic Information List
Table Vygon Transcutaneous Neurostimulators Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Vygon Transcutaneous Neurostimulators Sales Growth Rate (2012-2017)
Figure Vygon Transcutaneous Neurostimulators Sales Market Share in United States (2012-2017)
Figure Vygon Transcutaneous Neurostimulators Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Transcutaneous Neurostimulators
Figure Manufacturing Process Analysis of Transcutaneous Neurostimulators
Figure Transcutaneous Neurostimulators Industrial Chain Analysis
Table Raw Materials Sources of Transcutaneous Neurostimulators Major Players/Suppliers in 2016
Table Major Buyers of Transcutaneous Neurostimulators
Table Distributors/Traders List
Figure United States Transcutaneous Neurostimulators Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Transcutaneous Neurostimulators Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Transcutaneous Neurostimulators Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Transcutaneous Neurostimulators Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Transcutaneous Neurostimulators Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Transcutaneous Neurostimulators Sales Volume (K Units) Forecast by Type in 2022
Table United States Transcutaneous Neurostimulators Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Transcutaneous Neurostimulators Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Transcutaneous Neurostimulators Sales Volume (K Units) Forecast by Application in 2022
Table United States Transcutaneous Neurostimulators Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Transcutaneous Neurostimulators Sales Volume Share Forecast by Region (2017-2022)
Figure United States Transcutaneous Neurostimulators Sales Volume Share Forecast by Region (2017-2022)
Figure United States Transcutaneous Neurostimulators Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources